Answers are grounded in this paper and cite their sources.
The new analgesic tapentadol was evaluated for induction and inhibition of several cytochrome P450 enzymes in vitro, and protein binding was assessed. It was concluded that no clinically relevant drug – drug interactions are likely to occur through either mechanism.
No takes yet. Share an insight, caveat, or question.
Kneip et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: